Search News

Corporate Industry Technology Medical Updates

MoyoAssist

Corporate
From China to the Global Stage: magAssist Selected Among Fortune’s 23 Featured Healthcare Companies 2025-11-15
Medical Updates
"Spiral Escalation–De-escalation" Therapy for End-stage Heart Failure Recognized as a Major Clinical Technology in Guangzhou 2025-10-25
Industry
Showcasing magAssist's Extracorporeal Support Solutions at 36th Annual ELSO Conference 2025-09-30
Corporate
magAssist Recognized as a 2025 Potential Unicorn Enterprise in Jiangsu 2025-09-30
Medical Updates
Ventricular Assist Device Support for High-Risk PCI in a Patient with Acute Myocardial Infarction and Cardiogenic Shock 2025-09-26
Medical Updates
A Case Report: Use of Ventricular Assist Device to Enable High-Risk PCI in a Patient with Severe Left Ventricular Dysfunction 2025-09-07
Industry
Academic Symposium at Zhujiang Hospital Highlights Advances in Heart Failure Treatment with Extracorporeal VAD 2025-08-15
Corporate
magAssist Shortlisted for 2025 Prix Galien USA Best Start-Up Award 2025-08-14
Medical Updates
Zhujiang Hospital Transitions from ECMO + IABP to MoyoAssist® in the Management of Cardiogenic Shock 2025-04-30
Medical Updates
Rapid Postoperative Recovery Achieved with MoyoAssist® in High-Risk Cardiac Surgery 2025-04-12

Tabs： pVAD, cardiogenic shock, external life support systems, ECMO devices, IABP, Bridge-to-recovery, cardiogenic shock treatment, MoyoAssist Extra-VAD, solid technology of artificial hearts, Awards,